|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 1/20 | |
| C07K 14/33 |
| (11) | Number of the document | 2909307 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13786535.8 |
| Date of filing the European patent application | 2013-10-07 | |
| (97) | Date of publication of the European application | 2015-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/059183 |
| Date | 2013-10-07 |
| (87) | Number | WO 2014/060898 |
| Date | 2014-04-24 |
| (30) | Number | Date | Country code |
| 201261716605 P | 2012-10-21 | US |
| (72) |
JANSEN, Kathrin Ute, US
ANDERSON, Annaliesa Sybil, US
DONALD, Robert G.K., US
FLINT, Michael James, US
KALYAN, Narender Kumar, US
LOTVIN, Jason Arnold, US
SIDHU, Maninder K, US
MORAN, Justin Keith, US
RUPPEN, Mark Edward, US
SUN, Weiqiang, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN |
| COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN |